Effects of brown rice, rice bran, and polished rice on colon carcinogenesis in rats

Food Research International

Volumn 44, Issue 1, 2011, Pages 209-216

  Li, Sing Chung ^a   Chou, Tsui Chuan ^a   Shih, Chun Kuang ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aberrant crypt foci; Colon cancer; Cyclooxygenase 2; Mucin; Rice

Indexed keywords

ABERRANT CRYPT FOCI; COLON CANCER; CYCLOOXYGENASE-2; MUCIN; RICE;

OXIDATION; RATS;

PATHOLOGY;

RATTUS;

EID: 78651458661     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2010.10.034     Document Type: Article

References (68)

1. Aoe S., Oda T., Tojima T., Tanaka M., Tatsumi K., Mizutani T. Effects of rice bran hemicellulose on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in Fischer 344 rats. Nutrition and Cancer 1993, 20:41-49.
2. Aranganathan S., Nalini N. Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis. Food and Chemical Toxicology 2009, 47:2594-2600.
3. Arber N. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: Point. Cancer Epidemiology, Biomarkers & Prevention 2008, 17:1852-1857.
4. Arthur J.R., Boyne R. Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sciences 1985, 16:1569-1575.
5. Ashokkumar P., Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomedcine & Pharmacotherapy 2008, 62:590-597.
6. Baker M.A., Cerniglia G.J., Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Analytical Biochemistry 1990, 190:360-365.
7. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Letters 1987, 37:147-151.
8. Bird R.P. Aberrant crypt foci system to study cancer preventive agents in the colon. Tumor marker protocols 1998, 465-474. Humana Press Inc, Totowa. M. Hanausek, Z. Walaszek (Eds.).
9. Brown J.R., DuBois R.N. COX-2: A molecular target for colorectal cancer prevention. Journal of Clinical Oncology 2005, 23:2840-2855.
10. Caderni G., Femia A.P., Giannini A., Favuzza A., Luceri C., Salvadori M., et al. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: Correlation with carcinogenesis. Cancer Research 2003, 63:2388-2392.
11. Caderni G., Giannini A., Lancioni L., Luceri C., Biggeri A., Dolara P. Characterization of aberrant crypt foci in carcinogen-treated rats: Association with intestinal carcinogenesis. British Journal of Cancer 1995, 71:763-769.
12. Center M.M., Jemal A., Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiology, Biomarkers & Prevention 2009, 18:1688-1694.
13. Chatenoud L., La Vecchia C., Franceschi S., Tavani A., Jacobs D.R., Parpinel M.T., et al. Refined-cereal intake and risk of selected cancers in Italy. The American Journal of Clinical Nutrition 1999, 70:1107-1110.
14. Cianchi F., Cortesini C., Fantappie O., Messerini L., Sardi I., Lasagna N., et al. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clinical Cancer Research 2004, 10:2694-2704.
15. Corpet D.E., Tache S. Most effective colon cancer chemopreventive agents in rats: A review of aberrant crypt foci and tumour data, ranked by potency. Nutrition and Cancer 2002, 43:1-21.
16. Davies M., Gupta S., Goldspink G., Winslet M. The insulin-like growth factor system and colorectal cancer: Clinical and experimental evidence. International Journal of Colorectal Disease 2006, 21:201-208.
17. Deeptha K., Kamaleeswari M., Sengottuvelan M., Nalini N. Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats. Investigational New Drugs 2006, 24:479-488.
18. Femia A.P., Caderni G. Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Medica 2008, 74:1602-1607.
19. Ferrandez A., Prescott S., Burt R.W. COX-2 and colorectal cancer. Current Pharmaceutical Design 2003, 9:2229-2251.
20. Fox C.H., Eberl M. Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: A systematic review. Complementary Therapies in Medicine 2002, 10:229-234.
21. Giovannucci E. Insulin and colon cancer. Cancer Causes & Control 1995, 6:164-179.
22. Griesmacher A., Kindhauser M., Andert S.E., Schreiner W., Toma C., Knoebl P., et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. The American Journal of Medicine 1995, 98:469-475.
23. Hudson E.A., Dinh P.A., Kokubun T., Simmonds M.S.J., Gescher A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiology, Biomarkers & Prevention 2000, 9:1163-1170.
24. Inamine M., Suzui M., Morioka T., Kinjo T., Kaneshiro T., Sugishita T., et al. Inhibitory effect of dietary monoglucosyl-ceramide 1-O-beta-glucosyl-N-2?-hydroxyarachidoyl-4,8-sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats. Cancer Science 2005, 96:876-881.
25. Islam M.S., Murata T., Fujisawa M., Nagasaka R., Ushio H., Bari A.M., et al. Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. British Journal of Pharmacology 2008, 154:812-824.
26. Islam M.S., Yoshida H., Matsuki N., Ono K., Nagasaka R., Ushio H., et al. Antioxidant, free radical-scavenging, and NF-kappaB-inhibitory activities of phytosteryl ferulates: Structure-activity studies. Journal of Pharmacological Sciences 2009, 111:328-337.
27. Jariwalla R.J. Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine. Drugs under Experimental and Clinical Research 2001, 27:17-26.
28. Jenab M., Chen J.-M., Thompson L.U. Siaolomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Letters 2001, 165:19-25.
29. Kawabata K., Tanaka T., Murakami T., Okada T., Murai H., Yamamoto T., et al. Dietary prevention of azoxymethane-induced colon carcinogenesis with rice-germ in F344 rats. Carcinogenesis 1999, 20:2109-2115.
30. Kim Y.S., Milner J.A. Dietary modulation of colon cancer risk. The Journal of Nutrition 2007, 137:2576S-2579S.
31. Kong C.K.L., Lam W.S., Chiu L.C.M., Ooi V.E.C., Sun S.S.M., Wong Y.-S. A rice bran polyphenol, cycloartenyl ferulate, elicits apoptosis in human colorectal adenocarcinoma SW480 and sensitizes metastatic SW620 cells to TRAIL-induced apoptosis. Biochemical Pharmacology 2009, 77:1487-1496.
32. Kraus S., Arber N. Inflammation and colorectal cancer. Current Opinion in Pharmacology 2009, 9:405-410.
33. Larsson S.C., Giovannucci E., Bergkvist L., Wolk A. Whole grain consumption and risk of colorectal cancer: A population-based cohort of 60000 women. British Journal of Cancer 2005, 92:1803-1807.
34. Latifah S.Y., Armania N., Tze T.H., Azhar Y., Nordiana A.H., Norazalina S., et al. Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of beta-catenin and COX-2 in azoxymethane-induced colon cancer in rats. Nutrition Journal 2010, 9:16.
35. Lee S.-I., Moon H.-Y., Kwak J.-M., Kim J., Min B.-W., Um J.-W., et al. Relationship between meat and cereal consumption and colorectal cancer in Korea and Japan. Journal of Gastroenterology and Hepatology 2008, 23:138-140.
36. Lerma-García M.J., Herrero-Martínez J.M., Simó-Alfonso E.F., Mendonça C.R.B., Ramis-Ramos G. Composition, industrial processing and applications of rice bran ?-oryzanol. Food Chemistry 2009, 115:389-404.
37. Liao H.-F., Chen Y.-Y., Yang Y.-C., Wang C.-S., Chen Y.-J. Rice (Oryza sativa L.) inhibits growth and induces differentiation of human leukemic U937 cells through activation of peripheral blood mononuclear cells. Food and Chemical Toxicology 2006, 44:1724-1729.
38. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
39. No H.-N., Kwon H., Park Y.-G., Cheon C.-I., Park J.-S., Park T., et al. Dietary quercetin inhibits 1,2-dimethylhydrazine-induced liver DNA damage without altering colon DNA damage or precancerous lesion formation in rats. Nutrition Research 2007, 27:659-664.
40. Norazalina S., Norhaizan M.E., Hairuszah I., Norashareena M.S. Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Experimental and Toxicologic Pathology 2010, 62:259-268.
41. Ohta T., Takahashi M., Ochiai A. Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Letters 2005, 239:246-253.
42. Orlando F.A., Tan D., Baltodano J.D., Khoury T., Gibbs J.F., Hassid V.J., et al. Aberrant crypt foci as precursors in colorectal cancer progression. Journal of Surgical Oncology 2008, 98:207-213.
43. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005, 55:74-108.
44. Phutthaphadoong S., Yamada Y., Hirata A., Tomita H., Hara A., Limtrakul P., et al. Chemopreventive effect of fermented brown rice and rice bran (FBRA) on the inflammation-related colorectal carcinogenesis in ApcMin/+ mice. Oncology Reports 2010, 23:53-59.
45. Raju J. Azoxymethane-induced rat aberrant crypt foci: Relevance in studying chemoprevention of colon cancer. World Journal of Gastroenterology 2008, 14:6632-6635.
46. Rao C.V. Nitric oxide signaling in colon cancer chemoprevention. Mutation Research 2004, 555:107-119.
47. Roessner A., Kuestera D., Malfertheinerb P., Schneider-Stock R. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathology, Research and Practice 2008, 204:511-524.
48. Roschek B., Fink R.C., Li D., McMichael M., Tower C.M., Smith R.D., et al. Pro-inflammatory enzymes, cyclooxygenase 1, cyclooxygenase 2, and 5-lipooxygenase, inhibited by stabilized rice bran extracts. Journal of Medicinal Food 2009, 12:615-623.
49. Roy H.K., Karolski W.J., Patashak A. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. International Journal of Cancer 2001, 92:609-615.
50. Rukmini C. Phytochemical products: Rice bran. Phytochemical functional foods 2003, 347-376. Woodhead Publishing Ltd, Abington Cambridge. I. Johnson, G. Williamson (Eds.).
51. Schatzkin A., Mouw T., Park Y., Subar A.F., Kipnis V., Hollenbeck A., et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. The American Journal of Clinical Nutrition 2007, 85:1353-1360.
52. Seril D.N., Liao J., Yang G.-Y., Yang C.S. Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models. Carcinogenesis 2003, 24:353-362.
53. Shih C.-K., Chang J.-H., Yang S.-H., Chou T.-W., Cheng H.-H. beta-Carotene and canthaxanthin alter the pro-oxidation and antioxidation balance in rats fed a high-cholesterol and high-fat diet. The British Journal of Nutrition 2008, 99:59-66.
54. Shih C.-K., Chen S.-H., Hou W.C., Cheng H.-H. A high-resistance-starch rice diet reduces glycosylated hemoglobin levels and improves the antioxidant status in diabetic rats. Food Research International 2007, 40:842-847.
55. Shih C.-K., Chiang W., Kuo M.-L. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Food and Chemical Toxicology 2004, 42:1339-1347.
56. Slattery M.L., Curtin K.P., Edwards S.L., Schaffer D.M. Plant foods, fiber, and rectal cancer. The American Journal of Clinical Nutrition 2004, 79:274-281.
57. Sreedharan V., Venkatachalam K.K., Namasivayam N. Effect of morin on tissue lipid peroxidation and antioxidant status in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Investigational New Drugs 2009, 27:21-30.
58. Sunagawa N., Inamine M., Morioka T., Chiba I., Morita N., Aoki Y., et al. Inhibitory effect of rice bran-derived crude glycosphingolipid on colon preneoplastic biomarker lesions induced by azoxymethane in male F344 rats. Molecular Medicine Reports 2009, 2:45-49.
59. Takahashi M., Mutoh M., Kawamori T., Sugimura T., Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000, 21:1319-1327.
60. Takahashi M., Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Science 2004, 95:475-480.
61. Tsukamoto T., Kozaki K.-I., Nishikawa Y., Yamamoto M., Fukami H., Inoue M., et al. Development and distribution of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Japanese Journal of Cancer Research 1999, 90:720-725.
62. Uchida K., Kono S., Yin G., Toyomura K., Nagano J., Mizoue T., et al. Dietary fiber, source foods and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Scandinavian Journal of Gastroenterology 2010, 45:1223-1231.
63. Verschoyle R.D., Greaves P., Cai H., Edwards R.E., Steward W.P., Gescher A.J. Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. British Journal of Cancer 2007, 96:248-254.
64. Wang D., DuBois R.N. Prostaglandins and cancer. Gut 2006, 55:115-122.
65. Wheeler C.R., Salzman J.A., Elsayed N.M. Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Analytical Biochemistry 1990, 184:193-199.
66. Willcox J.K., Ash S.L., Catignani G.L. Antioxidants and prevention of chronic disease. Critical Reviews in Food Science and Nutrition 2004, 44:275-295.
67. Young G.P., Hu Y., Le Leu R.K., Nyskohus L. Dietary fibre and colorectal cancer: A model for environment-gene interactions. Molecular Nutrition & Food Research 2005, 49:571-584.
68. Zisman T.L., Rubin D.T. Colorectal cancer and dysplasia in inflammatory bowel disease. World Journal of Gastroenterology 2008, 17:2662-2669.